Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial Hypertension
Author(s) -
Steven M. Kawut,
Emilia Bagiella,
David J. Lederer,
Daichi Shimbo,
Evelyn M. Horn,
Kari E. Roberts,
Nicholas S. Hill,
R. Graham Barr,
Erika B. Rosenzweig,
Wendy S. Post,
Russell P. Tracy,
Harold I. Palevsky,
Paul M. Hassoun,
Reda E. Girgis
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.110.015693
Subject(s) - simvastatin , medicine , placebo , aspirin , randomized controlled trial , confidence interval , cardiology , anesthesia , surgery , pathology , alternative medicine
Pulmonary arterial hypertension (PAH) is a progressive disease that causes exercise limitation, heart failure, and death. We aimed to determine the safety and efficacy of aspirin and simvastatin in PAH.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom